CERo Therapeutics Valuation
| CEROW Stock | 0.01 0 25.64% |
CERo Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CERo Therapeutics from reviewing the firm fundamentals such as ebitda of (2.44 M), and Return On Asset of -0.88 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CERo Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of CERo Therapeutics is based on 3 months time horizon. Increasing CERo Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CERo stock is determined by what a typical buyer is willing to pay for full or partial control of CERo Therapeutics Holdings. Since CERo Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CERo Stock. However, CERo Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0147 | Real 0.013 | Hype 0.02 | Naive 0.0123 |
The intrinsic value of CERo Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CERo Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CERo Therapeutics Holdings helps investors to forecast how CERo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CERo Therapeutics more accurately as focusing exclusively on CERo Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CERo Therapeutics' intrinsic value based on its ongoing forecasts of CERo Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CERo Therapeutics' closest peers.
CERo Therapeutics Cash |
|
CERo Valuation Trend
Analysing the historical paterns of CERo Therapeutics' enterprise value and its market capitalization is a good way to estimate and gauge the value of CERo Therapeutics Holdings over time and is usually enough for investors to make rational market timing decisions.
CERo Valuation Data Drivers
CERo Therapeutics Total Value Analysis
CERo Therapeutics Holdings is currently estimated to have takeover price of 0 with market capitalization of 0, debt of 1.55 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CERo Therapeutics fundamentals before making investing decisions based on enterprise value of the companyCERo Therapeutics Asset Utilization
One of the ways to look at asset utilization of CERo is to check how much profit was generated for every dollar of assets it reports. CERo Therapeutics Holdings shows a negative utilization of assets of -0.88 percent, losing USD0.008757 for each dollar of assets held by the firm. Unproductive asset utilization signifies that the company is being less capable with each dollar of assets it shows. Put another way, asset utilization of CERo Therapeutics Holdings shows how inefficient it operates for each dollar spent on its assets.CERo Therapeutics Profitability Analysis
Net Loss for the year was (2.54 K) with profit before overhead, payroll, taxes, and interest of 0.About CERo Therapeutics Valuation
Our relative valuation model uses a comparative analysis of CERo Therapeutics. We calculate exposure to CERo Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CERo Therapeutics's related companies.CERo Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as CERo Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 6.5 M | |
| Shares Float | 1.1 M |
CERo Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of CERo Therapeutics Holdings and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value CERo we look at many different elements of the entity such as CERo's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CERo Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CERo Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CERo Therapeutics' worth.Additional Tools for CERo Stock Analysis
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.